「japan」の検索結果
77件：66～70件目を表示
-
tical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
eutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transien...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
tical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
eutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transien...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
临床试验信息 | 研究与开发 | 千寿制药株式会社
Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Disease 3 SJP-0132 China Completed NCT06717152 Healthy Volunt...
https://www.senju.co.jp/chinese/rd/trial.html